Skip to main content
. 2020 May 3;34(3):1377–1386. doi: 10.21873/invivo.11917

Table IV. Hazard ratios for overall survival (Cox hazard model).

graphic file with name in_vivo-34-1383-i0001.jpg

CI: Confidence interval; DFS: disease-free survival; ER: oestrogen receptor; HR: hazard ratio; mo: months; NAC: prior (neo) adjuvant anthracycline and/or taxane (including anthracycline and taxane-based regimens, anthracycline-based regimen only, and taxane-based regimen only); NR: not reached; PB: paclitaxel plus bevacizumab